375 related articles for article (PubMed ID: 21179119)
21. Malaria: deploying a candidate vaccine (RTS,S/AS02A) for an old scourge of humankind.
Alonso PL
Int Microbiol; 2006 Jun; 9(2):83-93. PubMed ID: 16835838
[TBL] [Abstract][Full Text] [Related]
22. Protection against a malaria challenge by sporozoite inoculation.
Roestenberg M; McCall M; Hopman J; Wiersma J; Luty AJ; van Gemert GJ; van de Vegte-Bolmer M; van Schaijk B; Teelen K; Arens T; Spaarman L; de Mast Q; Roeffen W; Snounou G; Rénia L; van der Ven A; Hermsen CC; Sauerwein R
N Engl J Med; 2009 Jul; 361(5):468-77. PubMed ID: 19641203
[TBL] [Abstract][Full Text] [Related]
23. Protective immunity against malaria liver stage after vaccination with live parasites.
Rénia L
Parasite; 2008 Sep; 15(3):379-83. PubMed ID: 18814710
[TBL] [Abstract][Full Text] [Related]
24. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
Good MF
Trends Immunol; 2005 Jun; 26(6):295-7. PubMed ID: 15922944
[TBL] [Abstract][Full Text] [Related]
25. Strong concordance between percent inhibition in oocyst and sporozoite intensities in a Plasmodium falciparum standard membrane-feeding assay.
Miura K; Swihart BJ; Deng B; Zhou L; Pham TP; Diouf A; Fay MP; Long CA
Parasit Vectors; 2019 May; 12(1):206. PubMed ID: 31060594
[TBL] [Abstract][Full Text] [Related]
26. A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.
Jaijyan DK; Singh H; Singh AP
J Biol Chem; 2015 Aug; 290(32):19496-511. PubMed ID: 25960542
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model.
Yoshida K; Iyori M; Blagborough AM; Salman AM; Dulal P; Sala KA; Yamamoto DS; Khan SM; Janse CJ; Biswas S; Yoshii T; Yusuf Y; Tokoro M; Hill AVS; Yoshida S
Sci Rep; 2018 Mar; 8(1):3896. PubMed ID: 29497047
[TBL] [Abstract][Full Text] [Related]
28. Blood-Stage Malaria Parasite Antigens: Structure, Function, and Vaccine Potential.
Salinas ND; Tang WK; Tolia NH
J Mol Biol; 2019 Oct; 431(21):4259-4280. PubMed ID: 31103771
[TBL] [Abstract][Full Text] [Related]
29. Novel ELISA method as exploratory tool to assess immunity induced by radiated attenuated sporozoites to decipher protective immunity.
Knepper TA; Duncan EH; Savransky T; Bergmann-Leitner ES
Malar J; 2017 Nov; 16(1):484. PubMed ID: 29187199
[TBL] [Abstract][Full Text] [Related]
30. Vaccination against malaria: targets, strategies and potentiation of immunity to blood stage parasites.
Taylor-Robinson AW
Front Biosci; 2000 Jan; 5():E16-29. PubMed ID: 10702381
[TBL] [Abstract][Full Text] [Related]
31. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.
Gowda DC; Wu X
Front Immunol; 2018; 9():3006. PubMed ID: 30619355
[TBL] [Abstract][Full Text] [Related]
32. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.
Spring M; Murphy J; Nielsen R; Dowler M; Bennett JW; Zarling S; Williams J; de la Vega P; Ware L; Komisar J; Polhemus M; Richie TL; Epstein J; Tamminga C; Chuang I; Richie N; O'Neil M; Heppner DG; Healer J; O'Neill M; Smithers H; Finney OC; Mikolajczak SA; Wang R; Cowman A; Ockenhouse C; Krzych U; Kappe SH
Vaccine; 2013 Oct; 31(43):4975-83. PubMed ID: 24029408
[TBL] [Abstract][Full Text] [Related]
33. Genetic engineering of attenuated malaria parasites for vaccination.
Khan SM; Janse CJ; Kappe SH; Mikolajczak SA
Curr Opin Biotechnol; 2012 Dec; 23(6):908-16. PubMed ID: 22560204
[TBL] [Abstract][Full Text] [Related]
34. The future for blood-stage vaccines against malaria.
Richards JS; Beeson JG
Immunol Cell Biol; 2009 Jul; 87(5):377-90. PubMed ID: 19417768
[TBL] [Abstract][Full Text] [Related]
35. The Development of Whole Sporozoite Vaccines for
Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK
Front Immunol; 2018; 9():2748. PubMed ID: 30619241
[TBL] [Abstract][Full Text] [Related]
36. Malaria infection by sporozoite challenge induces high functional antibody titres against blood stage antigens after a DNA prime, poxvirus boost vaccination strategy in Rhesus macaques.
Hamid MM; Remarque EJ; El Hassan IM; Hussain AA; Narum DL; Thomas AW; Kocken CH; Weiss WR; Faber BW
Malar J; 2011 Feb; 10():29. PubMed ID: 21303498
[TBL] [Abstract][Full Text] [Related]
37. Development of whole sporozoite malaria vaccines.
Hollingdale MR; Sedegah M
Expert Rev Vaccines; 2017 Jan; 16(1):45-54. PubMed ID: 27327875
[TBL] [Abstract][Full Text] [Related]
38. Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2.
Dejon-Agobe JC; Ateba-Ngoa U; Lalremruata A; Homoet A; Engelhorn J; Nouatin OP; Edoa JR; Fernandes JF; Esen M; Mouwenda YD; Betouke Ongwe EM; Massinga-Loembe M; Hoffman SL; Sim BKL; Theisen M; Kremsner PG; Adegnika AA; Lell B; Mordmüller B
Clin Infect Dis; 2019 Sep; 69(8):1377-1384. PubMed ID: 30561539
[TBL] [Abstract][Full Text] [Related]
39. Pre-erythrocytic malaria vaccines: towards greater efficacy.
Hill AV
Nat Rev Immunol; 2006 Jan; 6(1):21-32. PubMed ID: 16493425
[TBL] [Abstract][Full Text] [Related]
40. Whole parasite vaccination approaches for prevention of malaria infection.
Butler NS; Vaughan AM; Harty JT; Kappe SH
Trends Immunol; 2012 May; 33(5):247-54. PubMed ID: 22405559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
